Alligator Bioscience AB Stock: price and insider trades · Sweden

Alligator Bioscience AB, classified in the Health Care sector, is a listed company based in Lund, Sweden. Its insiders report their share dealings to Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Alligator Bioscience AB logged 5 filings by 4 insiders.

The flow runs one way only: 1 insider bought (1 purchase totalling €44k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Sören Bregenholt Frederiksen filed the largest purchase, €44k, on 25 September 2026, which represents 2.2% of the company's market value. Those buying include 1 chief executive.

For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 5 filings here. Since 2021, the database holds 1 purchase and 1 sale by insiders of the company.

The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 25 September 2026, which is 22 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 4 days. For comparison, MAR article 19 gives managers three business days to notify a trade.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.